deltatrials
Completed PHASE1 NCT01331486

Nitric Oxide Mediated Vasodilatory Response to Hawthorn Standardized Extract

Sponsor: University of North Carolina, Chapel Hill

Conditions Mild Hypertension Prehypertension
Interventions Hawthorn Placebo capsule
Updated 5 times since 2017 Last updated: Feb 6, 2013 Started: May 31, 2010 Primary completion: Jun 30, 2011 Completion: Jun 30, 2011

Listed as NCT01331486, this PHASE1 trial focuses on Mild Hypertension and Prehypertension and remains completed. Sponsored by University of North Carolina, Chapel Hill, it has been updated 5 times since 2010, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1

    First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of North Carolina, Chapel Hill
Data source: University of North Carolina, Chapel Hill

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Chapel Hill, United States